Option Therapeutics Inc OPTN
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 5.00M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- —
Valuation
Metric | OPTN |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | OPTN |
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 75.67 |
Interest Coverage | — |
Quick Ratio
OPTN
Profitability
Metric | OPTN |
|---|---|
Return on Assets (Normalized) | −102.43% |
Return on Equity (Normalized) | −107.35% |
Return on Invested Capital (Normalized) | −107.35% |
Return on Assets
OPTN
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|C#&??! | LOCK|fYdDN | $132B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|^sw!fT@ | LOCK|^xb& | $96B | |||
| Moderna Inc MRNA | LOCK|Bv@lCb | LOCK|Kt | $81B | |||
| argenx SE ADR ARGX | LOCK|?^cF@< | LOCK|#g | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|NmRdFjH | LOCK|Btt | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|^!>p%$> | LOCK|cfP$ | $30B | |||
| Incyte Corp INCY | LOCK|$kfdpNB | LOCK|>D< | $24B | |||
| BioNTech SE ADR BNTX | LOCK|CW$#xyx | LOCK|&& | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|!WLxjn | LOCK|nCG? | $20B | |||
| BridgeBio Pharma Inc BBIO | LOCK|@wh!c>r | LOCK|z@ | $15B |